| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |